Rifaximin for the treatment of newly diagnosed Crohn's disease: A case series

American Journal of Gastroenterology

Volumn 103, Issue 8, 2008, Pages 2158-2160

  Shafran, Ira ^a   Burgunder, Patricia ^a  

^a Shafran Gastroenterology Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; IRON; RIFAXIMIN; XIFANAN;

ABDOMINAL PAIN; ABSENCE OF SIDE EFFECTS; ADULT; CAPSULE ENDOSCOPY; CASE REPORT; COLONOSCOPY; COMPUTED TOMOGRAPHIC COLONOGRAPHY; CROHN DISEASE; DIARRHEA; DISEASE ACTIVITY; EDEMA; ERYTHEMA; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN TISSUE; INTESTINAL BLEEDING; INTESTINE ULCER; IRON DEFICIENCY ANEMIA; IRON THERAPY; LETTER; MALE; MONOTHERAPY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SERODIAGNOSIS; TREATMENT DURATION; TREATMENT OUTCOME; WEIGHT REDUCTION; WOUND HEALING;

ADULT; ANTI-INFECTIVE AGENTS; CROHN DISEASE; FEMALE; HUMANS; MALE; RIFAMYCINS;

EID: 49349094690     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2008.01982_16.x     Document Type: Letter

References (5)

1. Gionchetti P, Rizzello F, Lammers KM, et al. Antimicrobials in the management of inflammatory bowel disease. Digestion 2006 73 (Suppl 1 77 85.
2. Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: Antibiotics, probiotics, and prebiotics. Gastroenterology 2004 126 : 1620 33.
3. Rahimi R, Nikfar S, Rezaie A, et al. A meta-analysis of broad-spectrum antibiotic therapy in patients with active Crohn's disease. Clin Ther 2006 28 : 1983 8.
4. Shafran I, Johnson LK. An open-label evaluation of rifaximin in the treatment of active Crohn's disease. Curr Med Res Opin 2005 21 : 1165 9.
5. Prantera C, Lochs H, Campieri M, et al. Antibiotic treatment of Crohn's disease: Results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin. Aliment Pharmacol Ther 2006 23 : 1117 25.